Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023

特殊検査の世界市場予測(~2023年):感染症、内分泌科、腫瘍学、毒物学、免疫学、神経学、遺伝子検査

◆タイトル:Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023
◆商品コード:MAM-MD-5930
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年1月25日
◆ページ数:225
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、特殊検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、地域別分析、特殊検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Esoteric testing market projected to grow at a CAGR of 11.6%”The esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, and increasing government funding for the research and development of innovative esoteric tests. Moreover, the introduction of a new range of condition-specific markers and tests, with advances in genomics and proteomics, is expected to offer significant growth opportunities for market players during the forecast period. However, the dearth of skilled laboratory technicians and inadequate reimbursement will limit the growth of this market.

“The infectious diseases testing segment is expected to dominate the market during the forecast period”
In 2018, on the basis of type, the infectious diseases testing segment is expected to account for the largest share of the market during the forecast period.The large share of this segment is primarily attributed to the rising incidence/prevalence of target diseases (chronic, infectious, & lifestyle related diseases), the increasing adoption of advanced technologies, and the growing healthcare expenditure across the globe.
“The independent & reference laboratories segment is projected to be the fastest growing during the forecast period”
In 2018, on the basis of laboratory type, the independent & reference laboratories segment is expected to register the highest growth rate during the forecast period, owing to a large number of patient diagnosis undertaken for target diseases worldwide and competitive benefits offered by these providers over hospital-based laboratories.

“Asia Pacific is expected to register the highest growth rate during the forecast period”
Geographically, the esoteric testing market is segmented into North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, development in healthcare infrastructure, and significant rise in the disposable income in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 – 48%, Tier 2 – 40% and Tier 3 – 12%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

List of companies profiled in the report

• Labcorp (US)
• Quest Diagnostics (US)
• OPKO Health (US)
• Miraca holdings (Japan)
• Myriad Genetics (US)
• Sonic Healthcare (Australia)
• Primary Healthcare (Australia)
• Healthscope (Australia)
• Foundation Medicine (US)
• ACM Global Laboratories (US)
• Arup Laboratories (US)
• Fulgent Genetics (US)
• InVitae (US)
• Mayo Medical Laboratories (US)
• Spectra Laboratories (US)

Research Coverage
This report studies the esoteric testing market based on type, technology, laboratory type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall esoteric testing market and its segments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 REGIONAL SCOPE 17
1.4 YEARS CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 18
1.6 LIMITATIONS 18
1.7 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 20
2.1.1.1 Secondary sources 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Primary sources 22
2.1.2.2 Key industry insights 23
2.1.2.3 Breakdown of primaries 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 BOTTOM-UP APPROACH 24
2.2.2 TOP-DOWN APPROACH 25
2.3 DATA TRIANGULATION 26
2.4 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE ESOTERIC TESTING MARKET 33
4.2 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TYPE 34
4.3 ESOTERIC TESTING MARKET: REGIONAL GROWTH OPPORTUNITIES 35
4.4 ESOTERIC TESTING MARKET: REGIONAL MIX 36
4.5 ESOTERIC TESTING MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38

5.2.1 DRIVERS 39
5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic diseases 39
5.2.1.2 Increasing burden of infectious diseases 40
5.2.1.3 Rising demand for early disease detection using specialized diagnostic tests 41
5.2.1.4 Growing awareness of personalized medicine 41
5.2.1.5 Increasing funding and research grants for the development of innovative esoteric tests 41
5.2.2 RESTRAINTS 42
5.2.2.1 Unfavorable reimbursement scenario 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Condition-specific markers and tests with advances in genomics and proteomics 43
5.2.3.2 Growth opportunities in emerging countries 44
5.2.4 CHALLENGES 44
5.2.4.1 Changing regulatory landscape 44
6 INDUSTRY INSIGHTS 46
6.1 INTRODUCTION 46
6.2 INDUSTRY TRENDS 46
6.3 REGULATORY ANALYSIS 48
6.3.1 NORTH AMERICA 48
6.3.1.1 US 48
6.3.1.2 Canada 48
6.3.2 EUROPE 49
6.3.3 ASIA-PACIFIC 50
6.3.3.1 Japan 50
6.3.3.2 India 50
6.3.3.3 China 50
7 ESOTERIC TESTING MARKET, BY TYPE 51
7.1 INTRODUCTION 52
7.2 INFECTIOUS DISEASES TESTING 53
7.3 ENDOCRINOLOGY TESTING 57
7.4 ONCOLOGY TESTING 61
7.5 GENETIC TESTING 64
7.6 TOXICOLOGY TESTING 68
7.7 IMMUNOLOGY TESTING 71
7.8 NEUROLOGY TESTING 73
7.9 OTHERS 74

8 ESOTERIC TESTING MARKET, BY TECHNOLOGY 76
8.1 INTRODUCTION 77
8.2 CHEMILUMINESCENCE IMMUNOASSAY 78
8.3 ENZYME-LINKED IMMUNOSORBENT ASSAY 79
8.4 MASS SPECTROMETRY 80
8.5 REAL-TIME PCR 81
8.6 FLOW CYTOMETRY 82
8.7 RADIOIMMUNOASSAY 83
8.8 OTHER TECHNOLOGIES 84
9 GLOBAL ESOTERIC TESTING MARKET, BY LABORATORY TYPE 86
9.1 INTRODUCTION 87
9.2 INDEPENDENT & REFERENCE LABORATORIES 88
9.3 HOSPITAL LABORATORIES 89
10 ESOTERIC TESTING MARKET, BY REGION 91
10.1 INTRODUCTION 92
10.2 NORTH AMERICA 94
10.2.1 US 97
10.2.2 CANADA 100
10.3 EUROPE 103
10.3.1 GERMANY 106
10.3.2 FRANCE 108
10.3.3 UK 110
10.3.4 ITALY 113
10.3.5 SPAIN 115
10.3.6 REST OF EUROPE 117
10.4 ASIA PACIFIC 119
10.4.1 JAPAN 122
10.4.2 CHINA 124
10.4.3 INDIA 126
10.4.4 REST OF ASIA PACIFIC 128
10.5 LATIN AMERICA 130
10.5.1 BRAZIL 132
10.5.2 MEXICO 135
10.5.3 REST OF LATIN AMERICA 137
10.6 MIDDLE EAST & AFRICA 139

11 COMPETITIVE LANDSCAPE 142
11.1 OVERVIEW 142
11.2 MARKET SHARE ANALYSIS, 2016 143
11.3 COMPETITIVE SCENARIO 144
11.3.1 PRODUCT LAUNCHES 144
11.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 145
11.3.3 MERGERS AND ACQUISITIONS 146
11.3.4 EXPANSIONS 147
12 COMPANY PROFILES 148
(Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View.)*
12.1 LABCORP 148
12.2 QUEST DIAGNOSTICS 156
12.3 OPKO HEALTH 166
12.4 MIRACA HOLDINGS 170
12.5 MYRIAD GENETICS 173
12.6 SONIC HEALTHCARE 177
12.7 PRIMARY HEALTH CARE 180
12.8 HEALTHSCOPE 183
12.9 FOUNDATION MEDICINE 186
12.10 ACM GLOBAL LABORATORIES 190
12.11 ARUP LABORATORIES 192
12.12 FULGENT GENETICS 196
12.13 INVITAE 199
12.14 MAYO MEDICAL LABORATORIES 201
12.15 SPECTRA LABORATORIES 210
*Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 212
13.1 INSIGHTS OF INDUSTRY EXPERTS 212
13.2 DISCUSSION GUIDE 213
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 218
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 220
13.5 AVAILABLE CUSTOMIZATIONS 222
13.6 RELATED REPORTS 222
13.7 AUTHOR DETAILS 223

LIST OF TABLES

TABLE 1 NEW TESTS LAUNCHES BY KEY PLAYERS 43
TABLE 2 ESOTERIC TESTING MARKET: RECENT ACQUISITIONS 47
TABLE 3 ESOTERIC TESTING MARKET: RECENT COLLABORATIONS AND AGREEMENTS 47
TABLE 4 STRINGENCY OF REGULATIONS FOR CLINICAL LABORATORY ACCREDITATION,
BY COUNTRY 48
TABLE 5 ACCREDITATION BODIES IN EUROPE 49
TABLE 6 ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 52
TABLE 7 ESOTERIC TESTS FOR INFECTIOUS DISEASES, BY KEY MARKET PLAYER 53
TABLE 8 INFECTIOUS DISEASES ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 56
TABLE 9 ESOTERIC TESTS FOR ENDOCRINE DISEASES, BY KEY MARKET PLAYER 57
TABLE 10 ENDOCRINOLOGY ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 60
TABLE 11 ESOTERIC TESTS FOR ONCOLOGICAL DISEASES, BY KEY MARKET PLAYER 61
TABLE 12 ONCOLOGY ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 64
TABLE 13 ESOTERIC TESTS FOR GENETIC DISORDERS, BY KEY MARKET PLAYER 65
TABLE 14 GENETICS ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 67
TABLE 15 ESOTERIC TESTS FOR TOXICOLOGY, BY KEY MARKET PLAYER 68
TABLE 16 TOXICOLOGY ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 70
TABLE 17 ESOTERIC TESTS FOR IMMUNOLOGICAL DISEASES, BY KEY MARKET PLAYER 71
TABLE 18 IMMUNOLOGY ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 72
TABLE 19 ESOTERIC TESTS FOR NEUROLOGICAL DISORDERS, BY KEY MARKET PLAYER 73
TABLE 20 NEUROLOGY ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 74
TABLE 21 OTHER ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 75
TABLE 22 ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 77
TABLE 23 CHEMILUMINESCENCE IMMUNOASSAY MARKET FOR ESOTERIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 78
TABLE 24 ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET FOR ESOTERIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 79
TABLE 25 MASS SPECTROMETRY MARKET FOR ESOTERIC TESTING, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 80
TABLE 26 REAL-TIME PCR MARKET FOR ESOTERIC TESTING, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 81
TABLE 27 FLOW CYTOMETRY MARKET FOR ESOTERIC TESTING, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 83
TABLE 28 RADIOIMMUNOASSAY MARKET FOR ESOTERIC TESTING, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 84
TABLE 29 OTHER ESOTERIC TECHNOLOGIES MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 85
TABLE 30 ESOTERIC TESTING MARKET, BY LABORATORY TYPE, 2016–2023 (USD MILLION) 87
TABLE 31 ESOTERIC TESTING MARKET FOR INDEPENDENT & REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 89
TABLE 32 ESOTERIC TESTING MARKET FOR HOSPITAL LABORATORIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 90
TABLE 33 ESOTERIC TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 93
TABLE 34 NORTH AMERICA: ESOTERIC TESTING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 96
TABLE 35 NORTH AMERICA: ESOTERIC TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 96
TABLE 36 NORTH AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 97
TABLE 37 NORTH AMERICA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 97
TABLE 38 U.S.: INFECTIOUS DISEASE INCIDENCE, 2008-2012 98
TABLE 39 US: KEY MACROINDICATORS 99
TABLE 40 US: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 99
TABLE 41 US: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 100
TABLE 42 US: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 100
TABLE 43 CANADA: KEY MACROINDICATORS 101
TABLE 44 CANADA: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 101
TABLE 45 CANADA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 102
TABLE 46 CANADA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 102
TABLE 47 EUROPE: ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 105
TABLE 48 EUROPE: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 105
TABLE 49 EUROPE: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 106
TABLE 50 EUROPE: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 106
TABLE 51 GERMANY: KEY MACROINDICATORS 107
TABLE 52 GERMANY: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 107
TABLE 53 GERMANY: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 108
TABLE 54 GERMANY: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 108
TABLE 55 FRANCE: KEY MACROINDICATORS 109
TABLE 56 FRANCE: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 109
TABLE 57 FRANCE ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 110
TABLE 58 FRANCE: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 110
TABLE 59 UK: KEY MACROINDICATORS 111
TABLE 60 UK: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 61 UK: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 112
TABLE 62 UK: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 113
TABLE 63 ITALY: KEY MACROINDICATORS 113
TABLE 64 ITALY: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 114
TABLE 65 ITALY: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 114
TABLE 66 ITALY: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 115
TABLE 67 SPAIN: KEY MACROINDICATORS 115
TABLE 68 SPAIN: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 69 SPAIN: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 116
TABLE 70 SPAIN: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 117
TABLE 71 ROE: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 118
TABLE 72 ROE: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 118
TABLE 73 ROE: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 119
TABLE 74 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 121
TABLE 75 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 121
TABLE 76 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 122
TABLE 77 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 122
TABLE 78 JAPAN: KEY MACROINDICATORS 123
TABLE 79 JAPAN: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 123
TABLE 80 JAPAN: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 124
TABLE 81 JAPAN: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 124
TABLE 82 CHINA: KEY MACROINDICATORS 125
TABLE 83 CHINA: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 125
TABLE 84 CHINA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 126
TABLE 85 CHINA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 126
TABLE 86 INDIA: KEY MACROINDICATORS 127
TABLE 87 INDIA: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 88 INDIA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 128
TABLE 89 INDIA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 128
TABLE 90 ROAPAC: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 91 ROAPAC: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 129
TABLE 92 ROAPAC: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 130
TABLE 93 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 131
TABLE 94 LATIN AMERICA: ESOTERIC TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 131
TABLE 95 LATIN AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 132
TABLE 96 LATIN AMERICA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 132
TABLE 97 BRAZIL: KEY MACROINDICATORS 133
TABLE 98 BRAZIL: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 99 BRAZIL: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 134
TABLE 100 BRAZIL: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 135
TABLE 101 MEXICO: KEY MACROINDICATORS 136
TABLE 102 MEXICO: ESOTERIC TESTING MARKET, BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 103 MEXICO: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 137
TABLE 104 MEXICO: ESOTERIC TESTING MARKET, BY LABORATORY TYPE,
2016–2023 (USD MILLION) 137
TABLE 105 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 138
TABLE 106 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 138
TABLE 107 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE, 2016–2023 (USD MILLION) 139
TABLE 108 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY TYPE,
2016–2023 (USD MILLION) 140
TABLE 109 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 140
TABLE 110 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY LABORATORY TYPE, 2016–2023 (USD MILLION) 141


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 DATA TRIANGULATION METHODOLOGY 26
FIGURE 3 INFECTIOUS DISEASE TESTING SEGMENT TO DOMINATE THE GLOBAL ESOTERIC TESTING MARKET, BY TYPE, IN 2018 28
FIGURE 4 REAL-TIME PCR SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE ESOTERIC TESTING MARKET DURING THE FORECAST PERIOD 29
FIGURE 5 INDEPENDENT & REFERENCE LABORATORIES TO BE THE FASTEST-GROWING SEGMENT IN THE ESOTERIC TESTING MARKET BETWEEN 2018 & 2023 30
FIGURE 6 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 31
FIGURE 7 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES–KEY FACTOR DRIVING THE GROWTH OF THE ESOTERIC TESTING MARKET 33
FIGURE 8 GENETIC TESTING SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE APAC ESOTERIC TESTING MARKET DURING THE FORECAST PERIOD 34
FIGURE 9 EMERGING COUNTRIES TO REGISTER HIGHEST CAGR DURING
THE FORECAST PERIOD 35
FIGURE 10 NORTH AMERICA TO DOMINATE THE ESOTERIC TESTING MARKET
IN THE FORECAST PERIOD 36
FIGURE 11 DEVELOPING COUNTRIES TO REGISTER A HIGHER GROWTH RATE
IN THE FORECAST PERIOD 37
FIGURE 12 ESOTERIC TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 38
FIGURE 13 INCREASE IN GERIATRIC POPULATION, BY COUNTRY 2011 VS. 2015 VS. 2030 39
FIGURE 14 MAJOR TREND: ACQUISITIONS RESULTING IN MARKET CONSOLIDATION 46
FIGURE 15 ESOTERIC TESTING MARKET, BY TYPE, 2018 VS. 2023 52
FIGURE 16 CHEMILUMINESCENCE IMMUNOASSAY SEGMENT TO DOMINATE THE ESOTERIC TESTING MARKET DURING THE FORECAST PERIOD 77
FIGURE 17 ESOTERIC TESTING MARKET, BY LABORATORY TYPE, 2018 VS. 2023 87
FIGURE 18 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000–2014 92
FIGURE 19 NORTH AMERICA TO DOMINATE THE ESOTERIC TESTING MARKET IN 2023 93
FIGURE 20 GEOGRAPHIC SNAPSHOT OF THE GLOBAL ESOTERIC TESTING MARKET 94
FIGURE 21 NORTH AMERICA: ESOTERIC TESTING MARKET SNAPSHOT 95
FIGURE 22 EUROPE: ESOTERIC TESTING MARKET SNAPSHOT 104
FIGURE 23 ASIA PACIFIC: ESOTERIC TESTING MARKET SNAPSHOT 120
FIGURE 24 PLAYERS MAJORLY ADOPTED THE STRATEGY OF PRODUCT LAUNCHES BETWEEN JANUARY 2014 AND MARCH 2017 142
FIGURE 25 GLOBAL ESOTERIC TESTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 143
FIGURE 26 LABCORP: COMPANY SNAPSHOT 149
FIGURE 27 QUEST DIAGNOSTICS: COMPANY SNAPSHOT 156
FIGURE 28 OPKO HEALTH: COMPANY SNAPSHOT 166
FIGURE 29 MIRACA HOLDINGS: COMPANY SNAPSHOT 170
FIGURE 30 MYRIAD GENETICS: COMPANY SNAPSHOT 173
FIGURE 31 SONIC HEALTHCARE: COMPANY SNAPSHOT 178
FIGURE 32 PRIMARY HEALTH CARE: COMPANY SNAPSHOT 180
FIGURE 33 HEALTHSCOPE: COMPANY SNAPSHOT 183
FIGURE 34 FOUNDATION MEDICINE: COMPANY SNAPSHOT 186
FIGURE 35 FULGENT GENETICS: COMPANY SNAPSHOT 196
FIGURE 36 MAYO MEDICAL LABORATORIES: COMPANY SNAPSHOT 201
FIGURE 37 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT 210


【レポートのキーワード】

特殊検査、エソテリックテスト、感染症、内分泌科、腫瘍学、毒物学、免疫学、神経学、遺伝子検査

★調査レポート[特殊検査の世界市場予測(~2023年):感染症、内分泌科、腫瘍学、毒物学、免疫学、神経学、遺伝子検査] ( Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023 / MAM-MD-5930) 販売に関する免責事項
[特殊検査の世界市場予測(~2023年):感染症、内分泌科、腫瘍学、毒物学、免疫学、神経学、遺伝子検査] ( Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023 / MAM-MD-5930) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆